{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:38:30Z","timestamp":1792449510215,"version":"4.5.0"},"reference-count":108,"publisher":"Springer Science and Business Media LLC","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2025,3,11]]},"DOI":"10.7759\/cureus.80418","type":"journal-article","created":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T19:23:27Z","timestamp":1741721007000},"source":"Crossref","is-referenced-by-count":8,"title":["Epigenetic Mechanisms in the Transfer of Metabolic Disorders: A Comprehensive Review"],"prefix":"10.7759","author":[{"given":"Swathi","family":"NL","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zaid","family":"Shakhatreh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abeer","family":"Tahir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmeet","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samia","family":"Sulaiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athul","family":"H","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhilash","family":"Sadhankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Palak","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdulqadir J","family":"Nashwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","reference":[{"key":"ref1","unstructured":"Metabolic disorders. (2023). Accessed. June 16, 2023:  https:\/\/medlineplus.gov\/metabolicdisorders.html."},{"key":"ref2","doi-asserted-by":"publisher","DOI":"10.1136\/ejhpharm-2013-000398","article-title":"Metabolic disorders: an overview and key messages for pharmacists","volume":"21","author":"Patel R","year":"2014","unstructured":"Patel R. Metabolic disorders: an overview and key messages for pharmacists. Eur J Hosp Pharm. 2014, 21:355-60. 10.1136\/ejhpharm-2013-000398","journal-title":"Eur J Hosp Pharm"},{"key":"ref3","unstructured":"Diseases - Genetic and Rare Diseases Information Center. (2023). Accessed. June 16, 2023: https:\/\/rarediseases.info.nih.gov\/diseases?category=&page=1&letter=&search=."},{"key":"ref4","unstructured":"Obesity and overweight. (2023). Accessed. June 16, 2023: https:\/\/www.who.int\/news-room\/fact-sheets\/detail\/obesity-and-overweight."},{"key":"ref5","doi-asserted-by":"publisher","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the U.S. in 2012","volume":"36","author":"American Diabetes Association","year":"2013","unstructured":"American Diabetes Association. Economic costs of diabetes in the U.S. in 2012. Diabetes Care. 2013, 36:1033-46. 10.2337\/dc12-2625","journal-title":"Diabetes Care"},{"key":"ref6","doi-asserted-by":"publisher","DOI":"10.4103\/ijem.IJEM_579_17","article-title":"Emotional and psychological needs of people with diabetes","volume":"22","author":"Kalra S","year":"2018","unstructured":"Kalra S, Jena BN, Yeravdekar R. Emotional and psychological needs of people with diabetes. Indian J Endocrinol Metab. 2018, 22:696-704. 10.4103\/ijem.IJEM_579_17","journal-title":"Indian J Endocrinol Metab"},{"key":"ref7","doi-asserted-by":"publisher","DOI":"10.1097\/XCE.0000000000000315","article-title":"Efficacy and safety of double-dose statin monotherapy versus moderate-intensity statin combined with ezetimibe dual therapy in diabetic patients: a systematic review and meta-analysis of randomized controlled trials","volume":"13","author":"Goyal A","year":"2024","unstructured":"Goyal A, Tariq MD, Jain H, et al.. Efficacy and safety of double-dose statin monotherapy versus moderate-intensity statin combined with ezetimibe dual therapy in diabetic patients: a systematic review and meta-analysis of randomized controlled trials. Cardiovasc Endocrinol Metab. 2024, 13:e00315. 10.1097\/XCE.0000000000000315","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"ref8","doi-asserted-by":"publisher","DOI":"10.1126\/science.293.5532.1103","article-title":"Genes, genetics, and epigenetics: a correspondence","volume":"293","author":"Wu Ct","year":"2001","unstructured":"Wu Ct, Morris JR. Genes, genetics, and epigenetics: a correspondence. Science. 2001, 293:1103-5. 10.1126\/science.293.5532.1103","journal-title":"Science"},{"key":"ref9","doi-asserted-by":"publisher","DOI":"10.4137\/GEG.S32160","article-title":"Epigenetics and cellular metabolism","volume":"8","author":"Xu W","year":"2016","unstructured":"Xu W, Wang F, Yu Z, Xin F. Epigenetics and cellular metabolism. Genet Epigenet. 2016, 8:43-51. 10.4137\/GEG.S32160","journal-title":"Genet Epigenet"},{"key":"ref10","doi-asserted-by":"publisher","DOI":"10.1016\/j.cell.2007.02.006","article-title":"Epigenetics: a landscape takes shape","volume":"128","author":"Goldberg AD","year":"2007","unstructured":"Goldberg AD, Allis CD, Bernstein E. Epigenetics: a landscape takes shape. Cell. 2007, 128:635-8. 10.1016\/j.cell.2007.02.006","journal-title":"Cell"},{"key":"ref11","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1967-6","article-title":"Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets","volume":"54","author":"Yang BT","year":"2011","unstructured":"Yang BT, Dayeh TA, Kirkpatrick CL, et al.. Insulin promoter DNA methylation correlates negatively with insulin gene expression and positively with HbA(1c) levels in human pancreatic islets. Diabetologia. 2011, 54:360-7. 10.1007\/s00125-010-1967-6","journal-title":"Diabetologia"},{"key":"ref12","doi-asserted-by":"publisher","DOI":"10.1515\/BC.2008.048","article-title":"Role of histone modifications in defining chromatin structure and function","volume":"389","author":"Gelato KA","year":"2008","unstructured":"Gelato KA, Fischle W. Role of histone modifications in defining chromatin structure and function. Biol Chem. 2008, 389:353-63. 10.1515\/BC.2008.048","journal-title":"Biol Chem"},{"key":"ref13","doi-asserted-by":"publisher","DOI":"10.1038\/nbt.1685","article-title":"Epigenetic modifications and human disease","volume":"28","author":"Portela A","year":"2010","unstructured":"Portela A, Esteller M. Epigenetic modifications and human disease. Nat Biotechnol. 2010, 28:1057-68. 10.1038\/nbt.1685","journal-title":"Nat Biotechnol"},{"key":"ref14","doi-asserted-by":"publisher","DOI":"10.2337\/db13-0731","article-title":"The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients","volume":"63","author":"Vecellio M","year":"2014","unstructured":"Vecellio M, Spallotta F, Nanni S, et al.. The histone acetylase activator pentadecylidenemalonate 1b rescues proliferation and differentiation in the human cardiac mesenchymal cells of type 2 diabetic patients. Diabetes. 2014, 63:2132-47. 10.2337\/db13-0731","journal-title":"Diabetes"},{"key":"ref15","doi-asserted-by":"publisher","DOI":"10.1111\/j.1742-4658.2011.08042.x","article-title":"Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic \u03b2-islets","volume":"278","author":"Ramachandran D","year":"2011","unstructured":"Ramachandran D, Roy U, Garg S, Ghosh S, Pathak S, Kolthur-Seetharam U. Sirt1 and mir-9 expression is regulated during glucose-stimulated insulin secretion in pancreatic \u03b2-islets. FEBS J. 2011, 278:1167-74. 10.1111\/j.1742-4658.2011.08042.x","journal-title":"FEBS J"},{"key":"ref16","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2015.02.013","article-title":"Phosphorylation of epigenetic \"readers, writers and erasers\": implications for developmental reprogramming and the epigenetic basis for health and disease","volume":"118","author":"Trevi\u00f1o LS","year":"2015","unstructured":"Trevi\u00f1o LS, Wang Q, Walker CL. Phosphorylation of epigenetic \"readers, writers and erasers\": implications for developmental reprogramming and the epigenetic basis for health and disease. Prog Biophys Mol Biol. 2015, 118:8-13. 10.1016\/j.pbiomolbio.2015.02.013","journal-title":"Prog Biophys Mol Biol"},{"key":"ref17","doi-asserted-by":"publisher","DOI":"10.1097\/MD.0000000000039499","article-title":"Non-alcoholic fatty liver disease is associated with coronary flow reserve impairment: a pilot meta-analysis","volume":"103","author":"Jain H","year":"2024","unstructured":"Jain H, Pervez N, Dey D, et al.. Non-alcoholic fatty liver disease is associated with coronary flow reserve impairment: a pilot meta-analysis. Medicine (Baltimore). 2024, 103:e39499. 10.1097\/MD.0000000000039499","journal-title":"Medicine (Baltimore)"},{"key":"ref18","doi-asserted-by":"publisher","DOI":"10.1007\/s00011-020-01425-y","article-title":"Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition","volume":"70","author":"Ramos-Lopez O","year":"2021","unstructured":"Ramos-Lopez O, Milagro FI, Riezu-Boj JI, Martinez JA. Epigenetic signatures underlying inflammation: an interplay of nutrition, physical activity, metabolic diseases, and environmental factors for personalized nutrition. Inflamm Res. 2021, 70:29-49. 10.1007\/s00011-020-01425-y","journal-title":"Inflamm Res"},{"key":"ref19","doi-asserted-by":"publisher","DOI":"10.3390\/cells12162090","article-title":"The transcription factor HoxA5: novel insights into metabolic diseases and adipose tissue dysfunction","volume":"12","author":"Parrillo L","year":"2023","unstructured":"Parrillo L, Spinelli R, Longo M, et al.. The transcription factor HoxA5: novel insights into metabolic diseases and adipose tissue dysfunction. Cells. 2023, 12:2090. 10.3390\/cells12162090","journal-title":"Cells"},{"key":"ref20","doi-asserted-by":"publisher","DOI":"10.5414\/CN109525","article-title":"Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: differential expression profile of circulating lncRNA","volume":"92","author":"Yang Y","year":"2019","unstructured":"Yang Y, Lv X, Fan Q, Wang X, Xu L, Lu X, Chen T. Analysis of circulating lncRNA expression profiles in patients with diabetes mellitus and diabetic nephropathy: differential expression profile of circulating lncRNA. Clin Nephrol. 2019, 92:25-35. 10.5414\/CN109525","journal-title":"Clin Nephrol"},{"key":"ref21","doi-asserted-by":"publisher","DOI":"10.1093\/database\/baw159","article-title":"HEDD: the human epigenetic drug database","volume":"2016","author":"Qi Y","year":"2016","unstructured":"Qi Y, Wang D, Wang D, et al.. HEDD: the human epigenetic drug database. Database (Oxford). 2016, 2016:baw159. 10.1093\/database\/baw159","journal-title":"Database (Oxford)"},{"key":"ref22","doi-asserted-by":"publisher","DOI":"10.1002\/hsr2.70034","article-title":"Exercise-Induced cytokines, diet, and inflammation and their role in adipose tissue metabolism","volume":"7","author":"Al-Ibraheem AM","year":"2024","unstructured":"Al-Ibraheem AM, Hameed AA, Marsool MD, et al.. Exercise-Induced cytokines, diet, and inflammation and their role in adipose tissue metabolism. Health Sci Rep. 2024, 7:e70034. 10.1002\/hsr2.70034","journal-title":"Health Sci Rep"},{"key":"ref23","doi-asserted-by":"publisher","DOI":"10.3389\/fnbeh.2016.00107","article-title":"Waddington, dynamic systems, and epigenetics","volume":"10","author":"Tronick E","year":"2016","unstructured":"Tronick E, Hunter RG. Waddington, dynamic systems, and epigenetics. Front Behav Neurosci. 2016, 10:107. 10.3389\/fnbeh.2016.00107","journal-title":"Front Behav Neurosci"},{"key":"ref24","doi-asserted-by":"publisher","DOI":"10.1016\/j.tig.2022.03.010","article-title":"DNA methylation: a historical perspective","volume":"38","author":"Mattei AL","year":"2022","unstructured":"Mattei AL, Bailly N, Meissner A. DNA methylation: a historical perspective. Trends Genet. 2022, 38:676-707. 10.1016\/j.tig.2022.03.010","journal-title":"Trends Genet"},{"key":"ref25","doi-asserted-by":"publisher","DOI":"10.1186\/s13223-018-0259-4","article-title":"Histone modifications and their role in epigenetics of atopy and allergic diseases","volume":"14","author":"Alaskhar Alhamwe B","year":"2018","unstructured":"Alaskhar Alhamwe B, Khalaila R, Wolf J, et al.. Histone modifications and their role in epigenetics of atopy and allergic diseases. Allergy Asthma Clin Immunol. 2018, 14:39. 10.1186\/s13223-018-0259-4","journal-title":"Allergy Asthma Clin Immunol"},{"key":"ref26","doi-asserted-by":"publisher","DOI":"10.1093\/ilar.53.3-4.227","article-title":"Introduction: the use of animals models to advance epigenetic science","volume":"53","author":"Dolinoy DC","year":"2012","unstructured":"Dolinoy DC, Faulk C. Introduction: the use of animals models to advance epigenetic science. ILAR J. 2012, 53:227-31. 10.1093\/ilar.53.3-4.227","journal-title":"ILAR J"},{"key":"ref27","doi-asserted-by":"publisher","DOI":"10.1101\/cshperspect.a019497","article-title":"Epigenetics and human disease","volume":"8","author":"Zoghbi HY","year":"2016","unstructured":"Zoghbi HY, Beaudet AL. Epigenetics and human disease. Cold Spring Harb Perspect Biol. 2016, 8:a019497. 10.1101\/cshperspect.a019497","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"ref28","doi-asserted-by":"publisher","DOI":"10.2741\/4847","article-title":"Epigenetic alterations in cancer","volume":"25","author":"Ilango S","year":"2020","unstructured":"Ilango S, Paital B, Jayachandran P, Padma PR, Nirmaladevi R. Epigenetic alterations in cancer. Front Biosci (Landmark Ed). 2020, 25:1058-109. 10.2741\/4847","journal-title":"Front Biosci (Landmark Ed)"},{"key":"ref29","article-title":"Genetics, epigenetic mechanism","author":"Al Aboud NM","year":"2023","unstructured":"Al Aboud NM, Tupper C, Jialal I. Genetics, epigenetic mechanism. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref30","unstructured":"Histone modifications. (2023). Accessed. August 18, 2023: https:\/\/www.abcam.com\/epigenetics\/histone-modifications."},{"key":"ref31","unstructured":"Genetics, epigenetic mechanism. (2023). Accessed. June 16, 2023: https:\/\/www.ncbi.nlm.nih.gov\/books\/NBK532999\/."},{"key":"ref32","doi-asserted-by":"publisher","DOI":"10.1002\/edm2.514","article-title":"Efficacy of sodium-glucose cotransporter-2 inhibitors in patients with acute myocardial infarction: a meta-analysis of randomised controlled trials","volume":"7","author":"Ahmed M","year":"2024","unstructured":"Ahmed M, Jain H, Javaid H, Ahsan A, Szilagyi S, Ahmad A, Ahmed R. Efficacy of sodium-glucose cotransporter-2 inhibitors in patients with acute myocardial infarction: a meta-analysis of randomised controlled trials. Endocrinol Diabetes Metab. 2024, 7:e514. 10.1002\/edm2.514","journal-title":"Endocrinol Diabetes Metab"},{"key":"ref33","doi-asserted-by":"publisher","DOI":"10.1007\/s11523-020-00717-x","article-title":"microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside","volume":"15","author":"Ratti M","year":"2020","unstructured":"Ratti M, Lampis A, Ghidini M, Salati M, Mirchev MB, Valeri N, Hahne JC. microRNAs (miRNAs) and long non-coding RNAs (lncRNAs) as new tools for cancer therapy: first steps from bench to bedside. Target Oncol. 2020, 15:261-78. 10.1007\/s11523-020-00717-x","journal-title":"Target Oncol"},{"key":"ref34","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms14648","article-title":"The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers","volume":"8","author":"Alver BH","year":"2017","unstructured":"Alver BH, Kim KH, Lu P, et al.. The SWI\/SNF chromatin remodelling complex is required for maintenance of lineage specific enhancers. Nat Commun. 2017, 8:14648. 10.1038\/ncomms14648","journal-title":"Nat Commun"},{"key":"ref35","doi-asserted-by":"publisher","DOI":"10.1038\/s41580-021-00398-y","article-title":"The molecular principles of gene regulation by polycomb repressive complexes","volume":"22","author":"Blackledge NP","year":"2021","unstructured":"Blackledge NP, Klose RJ. The molecular principles of gene regulation by polycomb repressive complexes. Nat Rev Mol Cell Biol. 2021, 22:815-33. 10.1038\/s41580-021-00398-y","journal-title":"Nat Rev Mol Cell Biol"},{"key":"ref36","doi-asserted-by":"publisher","DOI":"10.4330\/wjc.v16.i11.619","article-title":"Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure","volume":"16","author":"Shah S","year":"2024","unstructured":"Shah S, Nawaz HS, Qazi MS, Jain H, Lucke-Wold B. Living biodrugs and how tissue source influences mesenchymal stem cell therapeutics for heart failure. World J Cardiol. 2024, 16:619-25. 10.4330\/wjc.v16.i11.619","journal-title":"World J Cardiol"},{"key":"ref37","doi-asserted-by":"publisher","DOI":"10.3390\/neuroglia5040029","article-title":"Microglia-associated neuroinflammation in Alzheimer\u2019s disease and its therapeutic potential","volume":"5","author":"Shah S","year":"2024","unstructured":"Shah S, Jain H. Microglia-associated neuroinflammation in Alzheimer\u2019s disease and its therapeutic potential. Neuroglia. 2024, 5:452-66. 10.3390\/neuroglia5040029","journal-title":"Neuroglia"},{"key":"ref38","doi-asserted-by":"publisher","DOI":"10.1007\/s12029-024-01157-w","article-title":"Demographics, prognostic factors, and survival outcomes in hepatic angiosarcoma: a retrospective analysis","volume":"56","author":"Wali A","year":"2024","unstructured":"Wali A, Robinson J, Iqbal A, et al.. Demographics, prognostic factors, and survival outcomes in hepatic angiosarcoma: a retrospective analysis. J Gastrointest Cancer. 2024, 56:33. 10.1007\/s12029-024-01157-w","journal-title":"J Gastrointest Cancer"},{"key":"ref39","doi-asserted-by":"publisher","DOI":"10.1016\/j.cois.2020.09.011","article-title":"Epigenetic regulation of post-embryonic development","volume":"43","author":"Palli SR","year":"2021","unstructured":"Palli SR. Epigenetic regulation of post-embryonic development. Curr Opin Insect Sci. 2021, 43:63-9. 10.1016\/j.cois.2020.09.011","journal-title":"Curr Opin Insect Sci"},{"key":"ref40","doi-asserted-by":"publisher","DOI":"10.1098\/rstb.2009.0125","article-title":"Epigenetic responses to environmental change and their evolutionary implications","volume":"364","author":"Turner BM","year":"2009","unstructured":"Turner BM. Epigenetic responses to environmental change and their evolutionary implications. Philos Trans R Soc Lond B Biol Sci. 2009, 364:3403-18. 10.1098\/rstb.2009.0125","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"ref41","doi-asserted-by":"publisher","DOI":"10.22045\/ibj.2016.01","article-title":"Role of epigenetics in biology and human diseases","volume":"20","author":"Moosavi A","year":"2016","unstructured":"Moosavi A, Motevalizadeh Ardekani A. Role of epigenetics in biology and human diseases. Iran Biomed J. 2016, 20:246-58. 10.22045\/ibj.2016.01","journal-title":"Iran Biomed J"},{"key":"ref42","doi-asserted-by":"publisher","DOI":"10.3390\/genes12020208","article-title":"Novel approaches to epigenetic therapies: from drug combinations to epigenetic editing","volume":"12","author":"Majchrzak-Celi\u0144ska A","year":"2021","unstructured":"Majchrzak-Celi\u0144ska A, Warych A, Szoszkiewicz M. Novel approaches to epigenetic therapies: from drug combinations to epigenetic editing. Genes (Basel). 2021, 12:208. 10.3390\/genes12020208","journal-title":"Genes (Basel)"},{"key":"ref43","doi-asserted-by":"publisher","DOI":"10.1016\/j.pbiomolbio.2015.02.011","article-title":"Elusive inheritance: transgenerational effects and epigenetic inheritance in human environmental disease","volume":"118","author":"Martos SN","year":"2015","unstructured":"Martos SN, Tang WY, Wang Z. Elusive inheritance: transgenerational effects and epigenetic inheritance in human environmental disease. Prog Biophys Mol Biol. 2015, 118:44-54. 10.1016\/j.pbiomolbio.2015.02.011","journal-title":"Prog Biophys Mol Biol"},{"key":"ref44","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01154-x","article-title":"DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application","volume":"13","author":"Hu C","year":"2021","unstructured":"Hu C, Liu X, Zeng Y, Liu J, Wu F. DNA methyltransferase inhibitors combination therapy for the treatment of solid tumor: mechanism and clinical application. Clin Epigenetics. 2021, 13:166. 10.1186\/s13148-021-01154-x","journal-title":"Clin Epigenetics"},{"key":"ref45","doi-asserted-by":"publisher","DOI":"10.3390\/molecules21111608","article-title":"Natural compound histone deacetylase inhibitors (HDACi): synergy with inflammatory signaling pathway modulators and clinical applications in cancer","volume":"21","author":"Losson H","year":"2016","unstructured":"Losson H, Schnekenburger M, Dicato M, Diederich M. Natural compound histone deacetylase inhibitors (HDACi): synergy with inflammatory signaling pathway modulators and clinical applications in cancer. Molecules. 2016, 21:1608. 10.3390\/molecules21111608","journal-title":"Molecules"},{"key":"ref46","doi-asserted-by":"publisher","DOI":"10.1093\/annonc\/mdx157","article-title":"BET inhibitors: a novel epigenetic approach","volume":"28","author":"Doroshow DB","year":"2017","unstructured":"Doroshow DB, Eder JP, LoRusso PM. BET inhibitors: a novel epigenetic approach. Ann Oncol. 2017, 28:1776-87. 10.1093\/annonc\/mdx157","journal-title":"Ann Oncol"},{"key":"ref47","doi-asserted-by":"publisher","DOI":"10.4018\/979-8-3693-1922-2.ch014","article-title":"Precision medicine and epigenetics: personalized diabetes care","author":"Swathi NL","year":"2024","unstructured":"Swathi NL, Basavan I, Muzzamil M, Venkatesan A, Rama GS, Arun A. Precision medicine and epigenetics: personalized diabetes care. Biomedical Research Developments for Improved Healthcare. Prabhakar PK (ed): IGI Global Publishing, 2024. 288-309. 10.4018\/979-8-3693-1922-2.ch014"},{"key":"ref48","doi-asserted-by":"publisher","DOI":"10.1016\/j.xcrm.2020.100125","article-title":"Coxsackievirus B type 4 infection in \u03b2 cells downregulates the chaperone prefoldin URI to induce a MODY4-like diabetes via Pdx1 silencing","volume":"1","author":"Bernard H","year":"2020","unstructured":"Bernard H, Teijeiro A, Chaves-P\u00e9rez A, et al.. Coxsackievirus B type 4 infection in \u03b2 cells downregulates the chaperone prefoldin URI to induce a MODY4-like diabetes via Pdx1 silencing. Cell Rep Med. 2020, 1:100125. 10.1016\/j.xcrm.2020.100125","journal-title":"Cell Rep Med"},{"key":"ref49","doi-asserted-by":"publisher","DOI":"10.1007\/978-3-319-31143-2_57-1","article-title":"Insulin action, insulin resistance, and their link to histone acetylation","author":"Balcerczyk A","year":"2017","unstructured":"Balcerczyk A, Chriett S, Pirola L. Insulin action, insulin resistance, and their link to histone acetylation. Handbook of Nutrition, Diet, and Epigenetics. Patel V, Preedy V (ed): Springer International Publishing, Cham, Switzerland; 2017. 1-22. 10.1007\/978-3-319-31143-2_57-1"},{"key":"ref50","doi-asserted-by":"publisher","DOI":"10.3390\/jcm8010087","article-title":"Altered adipose tissue DNA methylation status in metabolic syndrome: relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and inflammatory candidate genes and metabolic variables","volume":"8","author":"Castellano-Castillo D","year":"2019","unstructured":"Castellano-Castillo D, Moreno-Indias I, Sanchez-Alcoholado L, et al.. Altered adipose tissue DNA methylation status in metabolic syndrome: relationships between global DNA methylation and specific methylation at adipogenic, lipid metabolism and inflammatory candidate genes and metabolic variables. J Clin Med. 2019, 8:87. 10.3390\/jcm8010087","journal-title":"J Clin Med"},{"key":"ref51","doi-asserted-by":"publisher","DOI":"10.3390\/ijms150813494","article-title":"Non-coding RNAs and lipid metabolism","volume":"15","author":"Smolle E","year":"2014","unstructured":"Smolle E, Haybaeck J. Non-coding RNAs and lipid metabolism. Int J Mol Sci. 2014, 15:13494-513. 10.3390\/ijms150813494","journal-title":"Int J Mol Sci"},{"key":"ref52","doi-asserted-by":"publisher","DOI":"10.1161\/CIRCRESAHA.123.322135","article-title":"Epigenetics of early cardiometabolic disease: mechanisms and precision medicine","volume":"132","author":"Baccarelli AA","year":"2023","unstructured":"Baccarelli AA, Ordov\u00e1s J. Epigenetics of early cardiometabolic disease: mechanisms and precision medicine. Circ Res. 2023, 132:1648-62. 10.1161\/CIRCRESAHA.123.322135","journal-title":"Circ Res"},{"key":"ref53","doi-asserted-by":"publisher","DOI":"10.1038\/s41392-022-01055-2","article-title":"Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials","volume":"7","author":"Shi Y","year":"2022","unstructured":"Shi Y, Zhang H, Huang S, Yin L, Wang F, Luo P, Huang H. Epigenetic regulation in cardiovascular disease: mechanisms and advances in clinical trials. Signal Transduct Target Ther. 2022, 7:200. 10.1038\/s41392-022-01055-2","journal-title":"Signal Transduct Target Ther"},{"key":"ref54","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2022.2043590","article-title":"Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of collaborative cross mice fed an obesogenic high-fat and high-sucrose diet","volume":"17","author":"Tryndyak VP","year":"2022","unstructured":"Tryndyak VP, Willett RA, Avigan MI, Sanyal AJ, Beland FA, Rusyn I, Pogribny IP. Non-alcoholic fatty liver disease-associated DNA methylation and gene expression alterations in the livers of collaborative cross mice fed an obesogenic high-fat and high-sucrose diet. Epigenetics. 2022, 17:1462-76. 10.1080\/15592294.2022.2043590","journal-title":"Epigenetics"},{"key":"ref55","doi-asserted-by":"publisher","DOI":"10.1016\/j.cgh.2021.12.002","article-title":"2019 Global NAFLD prevalence: a systematic review and meta-analysis","volume":"20","author":"Le MH","year":"2022","unstructured":"Le MH, Yeo YH, Li X, et al.. 2019 Global NAFLD prevalence: a systematic review and meta-analysis. Clin Gastroenterol Hepatol. 2022, 20:2809-17. 10.1016\/j.cgh.2021.12.002","journal-title":"Clin Gastroenterol Hepatol"},{"key":"ref56","doi-asserted-by":"publisher","DOI":"10.1016\/j.molmet.2019.06.011","article-title":"Epigenetic disturbances in obesity and diabetes: epidemiological and functional insights","volume":"27","author":"Loh M","year":"2019","unstructured":"Loh M, Zhou L, Ng HK, Chambers JC. Epigenetic disturbances in obesity and diabetes: epidemiological and functional insights. Mol Metab. 2019, 27:S33-41. 10.1016\/j.molmet.2019.06.011","journal-title":"Mol Metab"},{"key":"ref57","doi-asserted-by":"publisher","DOI":"10.1007\/s13237-021-00376-x","article-title":"Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation","volume":"65","author":"Ghosh S","year":"2022","unstructured":"Ghosh S, Mahalanobish S, Sil PC. Diabetes: discovery of insulin, genetic, epigenetic and viral infection mediated regulation. Nucleus (Calcutta). 2022, 65:283-97. 10.1007\/s13237-021-00376-x","journal-title":"Nucleus (Calcutta)"},{"key":"ref58","article-title":"Metabolic consequences of weight reduction","author":"Farhana A","year":"2023","unstructured":"Farhana A, Rehman A. Metabolic consequences of weight reduction. StatPearls [Internet]. StatPearls Publishing, Treasure Island (FL); 2023."},{"key":"ref59","doi-asserted-by":"publisher","DOI":"10.3390\/ijms221910573","article-title":"The PPAR\u03b1 and PPAR\u03b3 epigenetic landscape in cancer and immune and metabolic disorders","volume":"22","author":"Porcuna J","year":"2021","unstructured":"Porcuna J, M\u00ednguez-Mart\u00ednez J, Ricote M. The PPAR\u03b1 and PPAR\u03b3 epigenetic landscape in cancer and immune and metabolic disorders. Int J Mol Sci. 2021, 22:10573. 10.3390\/ijms221910573","journal-title":"Int J Mol Sci"},{"key":"ref60","doi-asserted-by":"publisher","DOI":"10.3945\/an.113.004705","article-title":"Epigenetics in adipose tissue, obesity, weight loss, and diabetes","volume":"5","author":"Mart\u00ednez JA","year":"2014","unstructured":"Mart\u00ednez JA, Milagro FI, Claycombe KJ, Schalinske KL. Epigenetics in adipose tissue, obesity, weight loss, and diabetes. Adv Nutr. 2014, 5:71-81. 10.3945\/an.113.004705","journal-title":"Adv Nutr"},{"key":"ref61","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2019.1595297","article-title":"DNA methylation markers in obesity, metabolic syndrome, and weight loss","volume":"14","author":"Samblas M","year":"2019","unstructured":"Samblas M, Milagro FI, Mart\u00ednez A. DNA methylation markers in obesity, metabolic syndrome, and weight loss. Epigenetics. 2019, 14:421-44. 10.1080\/15592294.2019.1595297","journal-title":"Epigenetics"},{"key":"ref62","doi-asserted-by":"publisher","DOI":"10.1002\/mco2.292","article-title":"Post-translational modifications of histones: mechanisms, biological functions, and therapeutic targets","volume":"4","author":"Liu R","year":"2023","unstructured":"Liu R, Wu J, Guo H, et al.. Post-translational modifications of histones: mechanisms, biological functions, and therapeutic targets. MedComm (Beijing). 2023, 4:e292. 10.1002\/mco2.292","journal-title":"MedComm (Beijing)"},{"key":"ref63","doi-asserted-by":"publisher","DOI":"10.4161\/epi.21975","article-title":"Histone phosphorylation: a chromatin modification involved in diverse nuclear events","volume":"7","author":"Rossetto D","year":"2012","unstructured":"Rossetto D, Avvakumov N, C\u00f4t\u00e9 J. Histone phosphorylation: a chromatin modification involved in diverse nuclear events. Epigenetics. 2012, 7:1098-108. 10.4161\/epi.21975","journal-title":"Epigenetics"},{"key":"ref64","doi-asserted-by":"publisher","DOI":"10.1097\/MS9.0000000000002857","article-title":"Advances in diabetic cardiomyopathy: current and potential management strategies and emerging biomarkers","volume":"87","author":"Hassooni FRH","year":"2025","unstructured":"Hassooni FRH, Aljubori E, Abbas GMA, et al.. Advances in diabetic cardiomyopathy: current and potential management strategies and emerging biomarkers. Ann Med Surg. 2025, 87:224-33. 10.1097\/MS9.0000000000002857","journal-title":"Ann Med Surg"},{"key":"ref65","doi-asserted-by":"publisher","DOI":"10.1177\/18796397241287399","article-title":"Mortality trends and disparities in adults with Huntington's disease in the United States","volume":"13","author":"Saeed H","year":"2024","unstructured":"Saeed H, Abdullah, Hameed H, et al.. Mortality trends and disparities in adults with Huntington's disease in the United States. J Huntingtons Dis. 2024, 13:491-500. 10.1177\/18796397241287399","journal-title":"J Huntingtons Dis"},{"key":"ref66","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2022.868592","article-title":"Polycomb repressive complexes: shaping pancreatic beta-cell destiny in development and metabolic disease","volume":"10","author":"Varghese SS","year":"2022","unstructured":"Varghese SS, Dhawan S. Polycomb repressive complexes: shaping pancreatic beta-cell destiny in development and metabolic disease. Front Cell Dev Biol. 2022, 10:868592. 10.3389\/fcell.2022.868592","journal-title":"Front Cell Dev Biol"},{"key":"ref67","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2018.00402","article-title":"Overview of microRNA biogenesis, mechanisms of actions, and circulation","volume":"9","author":"O'Brien J","year":"2018","unstructured":"O'Brien J, Hayder H, Zayed Y, Peng C. Overview of microRNA biogenesis, mechanisms of actions, and circulation. Front Endocrinol (Lausanne). 2018, 9:402. 10.3389\/fendo.2018.00402","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref68","doi-asserted-by":"publisher","DOI":"10.3390\/ijms20225573","article-title":"Mechanisms and functions of long non-coding RNAs at multiple regulatory levels","volume":"20","author":"Zhang X","year":"2019","unstructured":"Zhang X, Wang W, Zhu W, Dong J, Cheng Y, Yin Z, Shen F. Mechanisms and functions of long non-coding RNAs at multiple regulatory levels. Int J Mol Sci. 2019, 20:5573. 10.3390\/ijms20225573","journal-title":"Int J Mol Sci"},{"key":"ref69","doi-asserted-by":"publisher","DOI":"10.1002\/advs.201900949","article-title":"CIRC-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells","volume":"7","author":"Chen L","year":"2020","unstructured":"Chen L, Kong R, Wu C, et al.. CIRC-MALAT1 functions as both an mRNA translation brake and a microRNA sponge to promote self-renewal of hepatocellular cancer stem cells. Adv Sci (Weinh). 2020, 7:1900949. 10.1002\/advs.201900949","journal-title":"Adv Sci (Weinh)"},{"key":"ref70","doi-asserted-by":"publisher","DOI":"10.1507\/endocrj.EJ19-0271","article-title":"Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1","volume":"67","author":"Cai H","year":"2020","unstructured":"Cai H, Jiang Z, Yang X, Lin J, Cai Q, Li X. Circular RNA HIPK3 contributes to hyperglycemia and insulin homeostasis by sponging miR-192-5p and upregulating transcription factor forkhead box O1. Endocr J. 2020, 67:397-408. 10.1507\/endocrj.EJ19-0271","journal-title":"Endocr J"},{"key":"ref71","doi-asserted-by":"publisher","DOI":"10.3390\/biology8010001","article-title":"Guide snoRNAs: drivers or passengers in human disease?","volume":"8","author":"Deogharia M","year":"2018","unstructured":"Deogharia M, Majumder M. Guide snoRNAs: drivers or passengers in human disease?. Biology (Basel). 2018, 8:e8010001. 10.3390\/biology8010001","journal-title":"Biology (Basel)"},{"key":"ref72","doi-asserted-by":"publisher","DOI":"10.3390\/biom10050783","article-title":"snoRNPs: functions in ribosome biogenesis","volume":"10","author":"Ojha S","year":"2020","unstructured":"Ojha S, Malla S, Lyons SM. snoRNPs: functions in ribosome biogenesis. Biomolecules. 2020, 10:783. 10.3390\/biom10050783","journal-title":"Biomolecules"},{"key":"ref73","doi-asserted-by":"publisher","DOI":"10.1016\/j.neulet.2016.04.046","article-title":"Epigenetic changes in diabetes","volume":"625","author":"Al-Haddad R","year":"2016","unstructured":"Al-Haddad R, Karnib N, Assaad RA, et al.. Epigenetic changes in diabetes. Neurosci Lett. 2016, 625:64-9. 10.1016\/j.neulet.2016.04.046","journal-title":"Neurosci Lett"},{"key":"ref74","doi-asserted-by":"publisher","DOI":"10.1002\/med.21878","article-title":"Epigenetic modifications in pancreas development, diabetes, and therapeutics","volume":"42","author":"Kaimala S","year":"2022","unstructured":"Kaimala S, Kumar CA, Allouh MZ, Ansari SA, Emerald BS. Epigenetic modifications in pancreas development, diabetes, and therapeutics. Med Res Rev. 2022, 42:1343-71. 10.1002\/med.21878","journal-title":"Med Res Rev"},{"key":"ref75","doi-asserted-by":"publisher","DOI":"10.1016\/j.freeradbiomed.2021.02.027","article-title":"Oxidative stress-mediated alterations in histone post-translational modifications","volume":"170","author":"Garc\u00eda-Gim\u00e9nez JL","year":"2021","unstructured":"Garc\u00eda-Gim\u00e9nez JL, Garc\u00e9s C, Rom\u00e1-Mateo C, Pallard\u00f3 FV. Oxidative stress-mediated alterations in histone post-translational modifications. Free Radic Biol Med. 2021, 170:6-18. 10.1016\/j.freeradbiomed.2021.02.027","journal-title":"Free Radic Biol Med"},{"key":"ref76","doi-asserted-by":"publisher","DOI":"10.2337\/db09-1003","article-title":"Epigenetics: a molecular link between environmental factors and type 2 diabetes","volume":"58","author":"Ling C","year":"2009","unstructured":"Ling C, Groop L. Epigenetics: a molecular link between environmental factors and type 2 diabetes. Diabetes. 2009, 58:2718-25. 10.2337\/db09-1003","journal-title":"Diabetes"},{"key":"ref77","doi-asserted-by":"publisher","DOI":"10.3390\/nu15040811","article-title":"Epigenetics in obesity and diabetes mellitus: new insights","volume":"15","author":"Su\u00e1rez R","year":"2023","unstructured":"Su\u00e1rez R, Chapela SP, \u00c1lvarez-C\u00f3rdova L, et al.. Epigenetics in obesity and diabetes mellitus: new insights. Nutrients. 2023, 15:811. 10.3390\/nu15040811","journal-title":"Nutrients"},{"key":"ref78","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(15)00127-8","article-title":"Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study","volume":"3","author":"Chambers JC","year":"2015","unstructured":"Chambers JC, Loh M, Lehne B, et al.. Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study. Lancet Diabetes Endocrinol. 2015, 3:526-34. 10.1016\/S2213-8587(15)00127-8","journal-title":"Lancet Diabetes Endocrinol"},{"key":"ref79","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2016.1178418","article-title":"DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk","volume":"11","author":"Dayeh T","year":"2016","unstructured":"Dayeh T, Tuomi T, Almgren P, et al.. DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk. Epigenetics. 2016, 11:482-8. 10.1080\/15592294.2016.1178418","journal-title":"Epigenetics"},{"key":"ref80","doi-asserted-by":"publisher","DOI":"10.1007\/s11892-017-0916-x","article-title":"The role of epigenetics in type 1 diabetes","volume":"17","author":"Jerram ST","year":"2017","unstructured":"Jerram ST, Dang MN, Leslie RD. The role of epigenetics in type 1 diabetes. Curr Diab Rep. 2017, 17:89. 10.1007\/s11892-017-0916-x","journal-title":"Curr Diab Rep"},{"key":"ref81","doi-asserted-by":"publisher","DOI":"10.1042\/BSR20202160","article-title":"Epigenetic modification and therapeutic targets of diabetes mellitus","volume":"40","author":"Singh R","year":"2020","unstructured":"Singh R, Chandel S, Dey D, Ghosh A, Roy S, Ravichandiran V, Ghosh D. Epigenetic modification and therapeutic targets of diabetes mellitus. Biosci Rep. 2020, 40:2160. 10.1042\/BSR20202160","journal-title":"Biosci Rep"},{"key":"ref82","doi-asserted-by":"publisher","DOI":"10.1111\/dom.13382","article-title":"MicroRNAs in islet hormone secretion","volume":"20","author":"Esguerra JL","year":"2018","unstructured":"Esguerra JL, Nagao M, Ofori JK, Wendt A, Eliasson L. MicroRNAs in islet hormone secretion. Diabetes Obes Metab. 2018, 20:11-9. 10.1111\/dom.13382","journal-title":"Diabetes Obes Metab"},{"key":"ref83","doi-asserted-by":"publisher","DOI":"10.1007\/s00125-010-1667-2","article-title":"Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes","volume":"53","author":"Herrera BM","year":"2010","unstructured":"Herrera BM, Lockstone HE, Taylor JM, et al.. Global microRNA expression profiles in insulin target tissues in a spontaneous rat model of type 2 diabetes. Diabetologia. 2010, 53:1099-109. 10.1007\/s00125-010-1667-2","journal-title":"Diabetologia"},{"key":"ref84","doi-asserted-by":"publisher","DOI":"10.1016\/j.cellimm.2009.10.012","article-title":"microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients","volume":"260","author":"Hezova R","year":"2010","unstructured":"Hezova R, Slaby O, Faltejskova P, et al.. microRNA-342, microRNA-191 and microRNA-510 are differentially expressed in T regulatory cells of type 1 diabetic patients. Cell Immunol. 2010, 260:70-4. 10.1016\/j.cellimm.2009.10.012","journal-title":"Cell Immunol"},{"key":"ref85","doi-asserted-by":"publisher","DOI":"10.1038\/nature03076","article-title":"A pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy MN","year":"2004","unstructured":"Poy MN, Eliasson L, Krutzfeldt J, et al.. A pancreatic islet-specific microRNA regulates insulin secretion. Nature. 2004, 432:226-30. 10.1038\/nature03076","journal-title":"Nature"},{"key":"ref86","doi-asserted-by":"publisher","DOI":"10.1111\/j.1463-1326.2012.01654.x","article-title":"Emerging roles of non-coding RNAs in pancreatic \u03b2-cell function and dysfunction","volume":"14","author":"Guay C","year":"2012","unstructured":"Guay C, Jacovetti C, Nesca V, Motterle A, Tugay K, Regazzi R. Emerging roles of non-coding RNAs in pancreatic \u03b2-cell function and dysfunction. Diabetes Obes Metab. 2012, 14:12-21. 10.1111\/j.1463-1326.2012.01654.x","journal-title":"Diabetes Obes Metab"},{"key":"ref87","doi-asserted-by":"publisher","DOI":"10.3390\/ijms22179462","article-title":"Epigenetic alterations related to gestational diabetes mellitus","volume":"22","author":"Valencia-Ortega J","year":"2021","unstructured":"Valencia-Ortega J, Saucedo R, S\u00e1nchez-Rodr\u00edguez MA, Cruz-Dur\u00e1n JG, Mart\u00ednez EG. Epigenetic alterations related to gestational diabetes mellitus. Int J Mol Sci. 2021, 22:9462. 10.3390\/ijms22179462","journal-title":"Int J Mol Sci"},{"key":"ref88","doi-asserted-by":"publisher","DOI":"10.1080\/15592294.2022.2110193","article-title":"Placental DNA methylation changes in gestational diabetes mellitus","volume":"17","author":"Chen F","year":"2022","unstructured":"Chen F, Fei X, Zhu W, et al.. Placental DNA methylation changes in gestational diabetes mellitus. Epigenetics. 2022, 17:2109-21. 10.1080\/15592294.2022.2110193","journal-title":"Epigenetics"},{"key":"ref89","doi-asserted-by":"publisher","DOI":"10.4103\/singaporemedj.SMJ-2022-232","article-title":"The impact of obesity: a narrative review","volume":"64","author":"Lam BC","year":"2023","unstructured":"Lam BC, Lim AY, Chan SL, Yum MP, Koh NS, Finkelstein EA. The impact of obesity: a narrative review. Singapore Med J. 2023, 64:163-71. 10.4103\/singaporemedj.SMJ-2022-232","journal-title":"Singapore Med J"},{"key":"ref90","doi-asserted-by":"publisher","DOI":"10.3389\/fendo.2021.706978","article-title":"Obesity: epidemiology, pathophysiology, and therapeutics","volume":"12","author":"Lin X","year":"2021","unstructured":"Lin X, Li H. Obesity: epidemiology, pathophysiology, and therapeutics. Front Endocrinol (Lausanne). 2021, 12:706978. 10.3389\/fendo.2021.706978","journal-title":"Front Endocrinol (Lausanne)"},{"key":"ref91","doi-asserted-by":"publisher","DOI":"10.1007\/s11154-023-09804-6","article-title":"Genetics and epigenetics in the obesity phenotyping scenario","volume":"24","author":"Trang K","year":"2023","unstructured":"Trang K, Grant SF. Genetics and epigenetics in the obesity phenotyping scenario. Rev Endocr Metab Disord. 2023, 24:775-93. 10.1007\/s11154-023-09804-6","journal-title":"Rev Endocr Metab Disord"},{"key":"ref92","doi-asserted-by":"publisher","DOI":"10.3390\/ijerph20064711","article-title":"Inherited epigenetic hallmarks of childhood obesity derived from prenatal exposure to obesogens","volume":"20","author":"N\u00fa\u00f1ez-S\u00e1nchez M\u00c1","year":"2023","unstructured":"N\u00fa\u00f1ez-S\u00e1nchez M\u00c1, Jim\u00e9nez-M\u00e9ndez A, Su\u00e1rez-Cort\u00e9s M, et al.. Inherited epigenetic hallmarks of childhood obesity derived from prenatal exposure to obesogens. Int J Environ Res Public Health. 2023, 20:4711. 10.3390\/ijerph20064711","journal-title":"Int J Environ Res Public Health"},{"key":"ref93","doi-asserted-by":"publisher","DOI":"10.3389\/fcell.2023.1188844","article-title":"Adipose tissue expansion in obesity, health, and disease","volume":"11","author":"White U","year":"2023","unstructured":"White U. Adipose tissue expansion in obesity, health, and disease. Front Cell Dev Biol. 2023, 11:1188844. 10.3389\/fcell.2023.1188844","journal-title":"Front Cell Dev Biol"},{"key":"ref94","doi-asserted-by":"publisher","DOI":"10.1016\/bs.acc.2020.09.005","article-title":"Epigenetics in kidney diseases","volume":"104","author":"Ding H","year":"2021","unstructured":"Ding H, Zhang L, Yang Q, Zhang X, Li X. Epigenetics in kidney diseases. Adv Clin Chem. 2021, 104:233-97. 10.1016\/bs.acc.2020.09.005","journal-title":"Adv Clin Chem"},{"key":"ref95","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpba.2018.10.042","article-title":"Succinic acid enhanced quantitative determination of blood modified nucleosides in the development of diabetic nephropathy based on hydrophilic interaction liquid chromatography mass spectrometry","volume":"164","author":"Guo M","year":"2019","unstructured":"Guo M, Liu D, Sha Q, Geng H, Liang J, Tang D. Succinic acid enhanced quantitative determination of blood modified nucleosides in the development of diabetic nephropathy based on hydrophilic interaction liquid chromatography mass spectrometry. J Pharm Biomed Anal. 2019, 164:309-16. 10.1016\/j.jpba.2018.10.042","journal-title":"J Pharm Biomed Anal"},{"key":"ref96","doi-asserted-by":"publisher","DOI":"10.3390\/cells11233711","article-title":"Role of adipose tissue microRNAs in the onset of metabolic diseases and implications in the context of the DOHaD","volume":"11","author":"Kappeler L","year":"2022","unstructured":"Kappeler L. Role of adipose tissue microRNAs in the onset of metabolic diseases and implications in the context of the DOHaD. Cells. 2022, 11:3711. 10.3390\/cells11233711","journal-title":"Cells"},{"key":"ref97","doi-asserted-by":"publisher","DOI":"10.2174\/1381612827666210315145254","article-title":"Harnessing the potential of long non-coding RNAs to manage metabolic diseases","volume":"27","author":"Bandesh K","year":"2021","unstructured":"Bandesh K, Masih D, Bhattacharyya N, Bharadwaj D. Harnessing the potential of long non-coding RNAs to manage metabolic diseases. Curr Pharm Des. 2021, 27:3668-85. 10.2174\/1381612827666210315145254","journal-title":"Curr Pharm Des"},{"key":"ref98","doi-asserted-by":"publisher","DOI":"10.4103\/0973-1482.204849","article-title":"Decitabine: an effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia","volume":"15","author":"Feng X","year":"2019","unstructured":"Feng X, Chen X, Nie S, et al.. Decitabine: an effective and safe treatment for myelodysplastic syndrome and acute myeloid leukemia. J Cancer Res Ther. 2019, 15:1471-6. 10.4103\/0973-1482.204849","journal-title":"J Cancer Res Ther"},{"key":"ref99","doi-asserted-by":"publisher","DOI":"10.1111\/1751-2980.12610","article-title":"Fatty liver mediated by peroxisome proliferator-activated receptor-\u03b1 DNA methylation can be reversed by a methylation inhibitor and curcumin","volume":"19","author":"Li YY","year":"2018","unstructured":"Li YY, Tang D, Du YL, Cao CY, Nie YQ, Cao J, Zhou YJ. Fatty liver mediated by peroxisome proliferator-activated receptor-\u03b1 DNA methylation can be reversed by a methylation inhibitor and curcumin. J Dig Dis. 2018, 19:421-30. 10.1111\/1751-2980.12610","journal-title":"J Dig Dis"},{"key":"ref100","doi-asserted-by":"publisher","DOI":"10.1186\/s11658-022-00344-6","article-title":"The role of epigenetic modifications in drug resistance and treatment of breast cancer","volume":"27","author":"Karami Fath M","year":"2022","unstructured":"Karami Fath M, Azargoonjahromi A, Kiani A, et al.. The role of epigenetic modifications in drug resistance and treatment of breast cancer. Cell Mol Biol Lett. 2022, 27:52. 10.1186\/s11658-022-00344-6","journal-title":"Cell Mol Biol Lett"},{"key":"ref101","doi-asserted-by":"publisher","DOI":"10.3390\/ijms23020843","article-title":"The dynamics and plasticity of epigenetics in diabetic kidney disease: therapeutic applications vis-\u00e0-vis","volume":"23","author":"Kuo FC","year":"2022","unstructured":"Kuo FC, Chao CT, Lin SH. The dynamics and plasticity of epigenetics in diabetic kidney disease: therapeutic applications vis-\u00e0-vis. Int J Mol Sci. 2022, 23:843. 10.3390\/ijms23020843","journal-title":"Int J Mol Sci"},{"key":"ref102","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-021-01069-7","article-title":"Advances in epigenetic therapeutics with focus on solid tumors","volume":"13","author":"Jin N","year":"2021","unstructured":"Jin N, George TL, Otterson GA, et al.. Advances in epigenetic therapeutics with focus on solid tumors. Clin Epigenetics. 2021, 13:83. 10.1186\/s13148-021-01069-7","journal-title":"Clin Epigenetics"},{"key":"ref103","doi-asserted-by":"publisher","DOI":"10.2147\/VHRM.S287082","article-title":"Epigenetic therapies for heart failure: current insights and future potential","volume":"17","author":"Napoli C","year":"2021","unstructured":"Napoli C, Bontempo P, Palmieri V, Coscioni E, Maiello C, Donatelli F, Benincasa G. Epigenetic therapies for heart failure: current insights and future potential. Vasc Health Risk Manag. 2021, 17:247-54. 10.2147\/VHRM.S287082","journal-title":"Vasc Health Risk Manag"},{"key":"ref104","doi-asserted-by":"publisher","DOI":"10.1016\/j.eururo.2021.03.005","article-title":"Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer","volume":"80","author":"Kumaraswamy A","year":"2021","unstructured":"Kumaraswamy A, Welker Leng KR, Westbrook TC, et al.. Recent advances in epigenetic biomarkers and epigenetic targeting in prostate cancer. Eur Urol. 2021, 80:71-81. 10.1016\/j.eururo.2021.03.005","journal-title":"Eur Urol"},{"key":"ref105","doi-asserted-by":"publisher","DOI":"10.3346\/jkms.2021.36.e85","article-title":"Recent clinical update of acute myeloid leukemia: focus on epigenetic therapies","volume":"36","author":"Lee E","year":"2021","unstructured":"Lee E, Koh Y, Hong J, Eom HS, Yoon SS. Recent clinical update of acute myeloid leukemia: focus on epigenetic therapies. J Korean Med Sci. 2021, 36:e85. 10.3346\/jkms.2021.36.e85","journal-title":"J Korean Med Sci"},{"key":"ref106","doi-asserted-by":"publisher","DOI":"10.1177\/2516865720988567","article-title":"Elucidation of epigenetic landscape in coronary artery disease: a review on basic concept to personalized medicine","volume":"14","author":"Sumi MP","year":"2021","unstructured":"Sumi MP, Mahajan B, Sattar RS, et al.. Elucidation of epigenetic landscape in coronary artery disease: a review on basic concept to personalized medicine. Epigenet Insights. 2021, 14:8567. 10.1177\/2516865720988567","journal-title":"Epigenet Insights"},{"key":"ref107","doi-asserted-by":"publisher","DOI":"10.3897\/pharmacia.70.e104097","article-title":"Pharmaco-epigenetics: histone modification and personalized medicine","volume":"70","author":"Sabi SH","year":"2023","unstructured":"Sabi SH, Qnais EYA, Al Tall YR, et al.. Pharmaco-epigenetics: histone modification and personalized medicine. Pharmacia. 2023, 70:337-49. 10.3897\/pharmacia.70.e104097","journal-title":"Pharmacia"},{"key":"ref108","doi-asserted-by":"publisher","DOI":"10.1186\/s13148-022-01263-1","article-title":"Ethical implications of epigenetics in the era of personalized medicine","volume":"14","author":"Santal\u00f3 J","year":"2022","unstructured":"Santal\u00f3 J, Berdasco M. Ethical implications of epigenetics in the era of personalized medicine. Clin Epigenetics. 2022, 14:44. 10.1186\/s13148-022-01263-1","journal-title":"Clin Epigenetics"}],"container-title":["Cureus"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.cureus.com\/articles\/346868-epigenetic-mechanisms-in-the-transfer-of-metabolic-disorders-a-comprehensive-review","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,11]],"date-time":"2025-03-11T19:23:32Z","timestamp":1741721012000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.cureus.com\/articles\/346868-epigenetic-mechanisms-in-the-transfer-of-metabolic-disorders-a-comprehensive-review"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3,11]]},"references-count":108,"URL":"https:\/\/doi.org\/10.7759\/cureus.80418","relation":{},"ISSN":["2168-8184"],"issn-type":[{"value":"2168-8184","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3,11]]}}}